Detail page

Knowledge Web

Person

Eugen Mengel (1963-)

Kinderarzt

Name	Eugen Mengel
Time	1963- (Date of birth and death)
Place	Erfurtshausen, Landkreis Marburg-Biedenkopf (Geburtsort) Deutschland
Academic degree	Dr. med.
Profession	Kinderarzt (characteristic profession) Arzt
Variant	Karl-Eugen Mengel
Related	SphinCS GmbH
Further information	Diss. Fachbereich Medizin an der Universität Mainz
Record type	Person
GND-Identifier	135623901
Record ID	135623901
Involved in show all Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE) Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP) A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD) Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B) Management, vaccination status and COVID-19 morbidity of patients with Gaucher disease in Germany during the COVID-19 pandemic Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results Niemann-Pick disease Niemann-Pick disease Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale Morbus Niemann-Pick Morbus Niemann-Pick Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry Diagnosis and Care of Infants and Children with Pompe Disease A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1 A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials Consensus clinical management guidelines for Niemann-Pick disease type C Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease Gaucher disease Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C) Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study Niemann-Pick disease type C symptomatology: an expert-based clinical description Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease Erratum to: Disease and patient characteristics in NP-C patients: findings from an international disease registry Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators Disease and patient characteristics in NP-C patients: findings from an international disease registry Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF) - more common than assumed? Report of four cases with transient NIHF and a review of the literature A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series The cognitive profile of type 1 Gaucher disease patients Invariant natural killer T cells are not affected by lysosomal storage in patients with N iemann‐ P ick disease type C Morbus Niemann-Pick Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool Eine neue Klassifikation der Sphingomyelinase-Defizienz Diagnose und Therapie des Morbus Gaucher Aktuelle Empfehlungen der deutschen Therapiezentren im Jahr 2000 : Aktuelle Empfehlungen der deutschen Therapiezentren im Jahr 2000

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Eugen Mengel (1963-)

Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment

A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE)

Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)

A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany

Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD)

Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

Management, vaccination status and COVID-19 morbidity of patients with Gaucher disease in Germany during the COVID-19 pandemic

Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results

Niemann-Pick disease

Niemann-Pick disease

Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective

Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study

Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale

Morbus Niemann-Pick

Morbus Niemann-Pick

Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study

Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry

Diagnosis and Care of Infants and Children with Pompe Disease

A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades

Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1

A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades

Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials

Consensus clinical management guidelines for Niemann-Pick disease type C

Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Gaucher disease

Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study

A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C)

Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency

Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency

Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

Niemann-Pick disease type C symptomatology: an expert-based clinical description

Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease

Erratum to: Disease and patient characteristics in NP-C patients: findings from an international disease registry

Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators

Disease and patient characteristics in NP-C patients: findings from an international disease registry

Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF) - more common than assumed? Report of four cases with transient NIHF and a review of the literature

A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations

Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series

The cognitive profile of type 1 Gaucher disease patients

Invariant natural killer T cells are not affected by lysosomal storage in patients with N iemann‐ P ick disease type C

Morbus Niemann-Pick

Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool

Eine neue Klassifikation der Sphingomyelinase-Defizienz

Diagnose und Therapie des Morbus Gaucher Aktuelle Empfehlungen der deutschen Therapiezentren im Jahr 2000 : Aktuelle Empfehlungen der deutschen Therapiezentren im Jahr 2000